Total planned funding: $107,352,823
Allocations
Countries/Regions
Asia Regional Program | $107,352,823 |
Organizational Types
NGO | $36,100,566 |
Own Agency | $33,196,529 |
University | $10,679,615 |
Unknown | $9,329,667 |
Host Country Government Agency | $7,709,278 |
Multi-lateral Agency | $5,860,608 |
Private Contractor | $4,010,112 |
Other USG Agency | $466,448 |
Implementing Agency | $0 |
Program Areas
Governance and Systems | $25,428,417 |
Treatment | $24,126,559 |
Management and Operations | $18,973,104 |
Prevention | $16,888,795 |
Testing | $12,567,056 |
Care | $9,368,892 |
Budget Codes
HTXS: Treatment: Adult Treatment | $23,660,951 |
HVMS: Management and Operations | $18,973,104 |
HVOP: Sexual Prevention: Other Sexual Prevention | $14,634,021 |
HVCT: Testing: HIV Testing and Counseling | $12,567,056 |
OHSS: Health Systems Strengthening | $11,946,540 |
HVSI: Strategic Information | $9,890,084 |
HBHC: Care: Adult Care and Support | $7,129,870 |
HLAB: Laboratory Infrastructure | $3,591,793 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $1,768,674 |
HKID: Care: Orphans and Vulnerable Children | $1,244,726 |
PDCS: Care: Pediatric Care and Support | $626,310 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $431,488 |
HVTB: Care: TB/HIV | $367,986 |
PDTX: Treatment: Pediatric Treatment | $290,108 |
HTXD: Treatment: ARV Drugs | $175,500 |
HMBL: Biomedical Prevention: Blood Safety | $54,612 |
Top Partner Programs
U.S. Centers for Disease Control and Prevention:
$18,507,999
Countries/Regions
Asia Regional Program
2013 | $7,070,000 |
2020 | $11,437,999 |
Not Available:
$6,943,486
Countries/Regions
Asia Regional Program
2013 | $0 |
2015 | $1,400,000 |
2020 | $5,543,486 |
U.S. Agency for International Development:
$6,595,932
Countries/Regions
Asia Regional Program
2013 | $1,015,733 |
2020 | $5,580,199 |